Danyue Peng
Overview
Explore the profile of Danyue Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Peng D, Deng J, Xiong L, Yin P, Hu J, et al.
Cancer Med
. 2024 Oct;
13(20):e70317.
PMID: 39440695
Background: Since the development of the first-generation Tyrosine Kinase Inhibitor (TKI), it has played a crucial role in the treatment of BCR::ABL1-positive acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia...
2.
Chen Y, Wen J, Li Q, Peng D, Liao C, Ma X, et al.
Leukemia
. 2023 Nov;
38(2):266-280.
PMID: 38036630
The fate of leukaemia stem cells (LSCs) is determined by both their inherent mechanisms and crosstalk with their niches. Although LSCs were confirmed to be eradicated by restarting senescence, the...
3.
Wen J, Chen Y, Liao C, Ma X, Wang M, Li Q, et al.
Cancer Lett
. 2023 Sep;
575:216407.
PMID: 37769796
Most patients with acute myeloid leukemia (AML) relapse eventually because of the inability to effectively eliminate leukemia stem cells (LSCs), prompting the search of new therapies to eradicate LSCs. Our...
4.
Hong M, Peng D, Fu A, Wang X, Zheng Y, Xia L, et al.
J Cell Mol Med
. 2023 Feb;
27(4):506-514.
PMID: 36722317
Traditional microbiological methodology has limited sensitivity, detection range, and turnaround times in diagnosis of bloodstream infection in Febrile Neutropenia (FN) patients. A more rapid and sensitive detection technology is urgently...
5.
Qian C, Wu Q, Ruan Z, Liu F, Li W, Shi W, et al.
Infect Drug Resist
. 2023 Jan;
16:201-215.
PMID: 36644657
Background: Bloodstream infection (BSI) due to carbapenem-resistant organisms (CROs) has emerged as a worldwide problem associated with high mortality. This study aimed to evaluate the risk factors associated with mortality...
6.
Niu J, Peng D, Liu L
Front Oncol
. 2022 Jul;
12:896426.
PMID: 35865470
Acute myeloid leukemia (AML) is a polyclonal and heterogeneous hematological malignancy. Relapse and refractory after induction chemotherapy are still challenges for curing AML. Leukemia stem cells (LSCs), accepted to originate...
7.
Li X, Ma X, Chen Y, Peng D, Wang H, Chen S, et al.
Stem Cells Transl Med
. 2020 Jul;
9(12):1604-1616.
PMID: 32602209
The stemness of ex vivo expanded hematopoietic stem cells (HSCs) is usually compromised by current methods. To explore the failure mechanism of stemness maintenance of human HSCs, which were expanded...
8.
Peng D, Wang H, Li L, Ma X, Chen Y, Zhou H, et al.
Leukemia
. 2018 Feb;
32(5):1180-1188.
PMID: 29479064
Leukemia stem cells (LSCs) are responsible for acute myeloid leukemia (AML) chemotherapy resistance and relapse. Here, we discovered that miR-34c-5p, a microRNA central to the senescence regulation network, was significantly...